Determination of tenofovir in pharmaceutical formulation by zero order and first order derivative UV-spectrophotometry methods

Research Journal of Chemistry and Environment

Volumn 12, Issue 1, 2008, Pages 49-50

  Shirkhedkar Atul, A ^a   Bhirud Charushila, H ^a   Surana Sanjay, J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

First order derivative spectrophotometry; Tenofovir; Zero order UV spectrophotometry

Indexed keywords

CONCENTRATION (COMPOSITION); DRUG; ESTIMATION METHOD; SOFTWARE; SPECTROPHOTOMETRY; ULTRAVIOLET RADIATION;

EID: 42149118336     PISSN: 09720626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Arimilli M. et al, Antiviral Chem. and Chemother., 8, 557 (1997)
2. th edn., Published by Merck and Co, White House Station, NJ, USA, 5146 (2006)
3. Gallant J.E., Staszewaski S. and Pozniak A.L., Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients, J. Amer. Med. Assoc. 292, 191 (2004)
4. King T., Bushman L. and Kiser J., Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells, J. Chromatogr. B, 843(2, 7), 147-156 (2006)
5. Naser L. Rezk, Rustin D. Crutchley and Angela Kashuba D.M., Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction, J. Chromatogr. B; 822(1-2), 201-208 (2005)
6. Sentenac S. et al, Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography, J.Chromatogr B, 793(2), 317-324 (2003)
7. th edn., Rockville, MD, The United States Pharmacopoeial Convention, Inc: 2749-2751 (2005)